The pharmaceutical industry applies evolving scientific knowledge to create new drugs and potential life-saving therapies. Pharmaceutical companies also reap significant financial gains from their drug and therapeutic developments.
The pharmaceutical industry applies evolving scientific knowledge to create new drugs and potential life-saving therapies. Pharmaceutical companies also reap significant financial gains from their drug and therapeutic developments. This monetary incentive could potentially result in aggressive inter-pharmaceutical company espionage. In this novel, a profiteering pharmaceutical executive seizes upon an opportunity to turn the discovery of a new cancer-preventing drug into a massive industry-competitive advantage for his company and his own personal financial gain. Using ruthless individuals with deadly skills and intent, the executive tries to nefariously obtain the necessary molecular synthesis protocol to create the next generation of oncologic drugs. Through a detailed medical and scientific investigation, doctors, scientists, and law enforcement agencies work together to quickly understand and identify what is occurring in the shadows. This is a frightening story of scientific discovery versus greed and the quest for money. At the end of the audiobook, the listeners will need to ask themselves the underlying question: Is this story really fiction?
To Cure or Kill (Unabridged) is available as an audiobook on Apple Books. We haven't confirmed it on Spotify yet — but you can still search there below.
Retailer links open each store's page for this title. As an Amazon Associate, FindMyTBR may earn from qualifying purchases — see our affiliate disclosure.
FindMyTBR aggregates audiobook availability across Spotify, Apple Books, Audible, and Amazon so you can
move your Goodreads TBR to audio. Availability reflects titles we've confirmed; a service with no badge
just hasn't been confirmed yet. Covers via Open Library.
Search your whole Goodreads shelf →